Aciceda Therapeutics LogoHome
Home Our Approach Pipeline and Programs Publications News and Events Careers About Us Contact
View Linkedin View Twitter

Pipeline and Programs

Multiple targets under investigation across broad therapeutic areas. Active preclinical, IND, and clinical programs, with 1 recruiting clinical trial in Geographic Atrophy already underway.

Background image Ophthalmology Geographic Atrophy - AVD-104 Ophthalmology Geographic Atrophy - AVD-104 Background image Ophthalmology Diabetic Macular Edema - AVD-104 Ophthalmology Diabetic Macular Edema - AVD-104 Background image Ophthalmology Diabetic retinopathy - AVD-302 Ophthalmology Diabetic retinopathy - AVD-302 Background image Fibrosis Myelofibrosis Fibrosis Myelofibrosis Background image Inflammation Lung inflammation Inflammation Lung inflammation Background image Neuroinflammation CNS injury Neuroinflammation CNS injury Background image Oncology Solid tumors Oncology Solid tumors
Discovery
Preclinical
IND-enabling
Phase 2/3

Ophthalmology

Geographic Atrophy
Diabetic Macular Edema
Other Eye Indications Diabetic Retinopathy, Uveitis, Others

Fibrosis

Idiopathic Pulmonary Fibrosis
Liver Fibrosis
Myelofibrosis

Immunology

Lung Inflammation

Neurology

Neurodegeneration Alzheimer’s Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis
Neuroinflammation Alzheimer’s Disease, Multiple Sclerosis, Spinal Cord Injury, Stroke

Oncology

Solid Tumors